StockData
CervoMed Inc. logo

CervoMed Inc. (CRVO) stock

CRVONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$1.50−0.17 (-10.18%)

Close on Nov 17, 2026Market cap $22.68MP/E –Yield –

CervoMed profit margin

Profit margin (net margin) is net income as a percentage of revenue.

CervoMed's profit margin for the twelve months ending Jun 30, 2026 was -9160.9%. For fiscal 2025 it was -673.1%, against -167.3% the year before. The highest annual figure on record is -30.4% in fiscal 2023.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-673.1%−505.8
FY2024Dec 31, 2024-167.3%−136.9
FY2023Dec 31, 2023-30.4%+3399.3
FY2013Dec 31, 2013-3429.7%−1595.7
FY2012Dec 31, 2012-1833.9%+2133.9
FY2011Dec 31, 2011-3967.9%+16957.3
FY2010Dec 31, 2010-20925.1%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q4 FY2025Dec 31, 2025-92680.4%−92370.2
Q3 FY2025Sep 30, 2025-2395.3%−2150.3
Q2 FY2025Jun 30, 2025-356.1%−285.6
Q1 FY2025Mar 31, 2025-255.2%−148.1
Q4 FY2024Dec 31, 2024-310.2%−215.3
Q3 FY2024Sep 30, 2024-245.1%−385.9
Q2 FY2024Jun 30, 2024-70.4%+12.4
Q1 FY2024Mar 31, 2024-107.1%−69.2
Q4 FY2023Dec 31, 2023-94.9%–
Q3 FY2023Sep 30, 2023140.9%–
Q2 FY2023Jun 30, 2023-82.9%–
Q1 FY2023Mar 31, 2023-38.0%–

More CervoMed figures

See a number that looks wrong?